Cis-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
The present invention provides MDM2 inhibitor compounds of Formula (I), or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharma...
Saved in:
Main Authors | , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
01.03.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides MDM2 inhibitor compounds of Formula (I), or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor. |
---|---|
AbstractList | The present invention provides MDM2 inhibitor compounds of Formula (I), or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor. |
Author | Sun, Daqing Yan, Xuelei Beck, Hilary Plake Degraffenreid, Michael R Medina, Julio C Gonzalez Lopez De Turiso, Felix Kayser, Frank Bartberger, Michael D Julian, Lisa D Rew, Yosup Fox, Brian M Olson, Steven H Roveto, Philip M |
Author_xml | – fullname: Yan, Xuelei – fullname: Beck, Hilary Plake – fullname: Olson, Steven H – fullname: Fox, Brian M – fullname: Julian, Lisa D – fullname: Degraffenreid, Michael R – fullname: Roveto, Philip M – fullname: Bartberger, Michael D – fullname: Sun, Daqing – fullname: Gonzalez Lopez De Turiso, Felix – fullname: Medina, Julio C – fullname: Rew, Yosup – fullname: Kayser, Frank |
BookMark | eNqNyr8KwjAQgPEMOvjvHW5wLbRREUdbFZdO6lxieiGB9i4k5_ur4AM4ffDxm6sJMeFM3ZqQi5FT9DyE7wJDPbB4TGB5jPyiPoPJ0J5aDYF8eAbhlMFxgo8CSWhkRBJgB9aQxbRUU2eGjKtfF2p9Od-ba4GRO8zRWCSU7vjQZbXV1aHc7-pab_5kb6mqOv8 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AU2014219075BB2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU2014219075BB23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:38:08 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU2014219075BB23 |
Notes | Application Number: AU20140219075 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180301&DB=EPODOC&CC=AU&NR=2014219075B2 |
ParticipantIDs | epo_espacenet_AU2014219075BB2 |
PublicationCentury | 2000 |
PublicationDate | 20180301 |
PublicationDateYYYYMMDD | 2018-03-01 |
PublicationDate_xml | – month: 03 year: 2018 text: 20180301 day: 01 |
PublicationDecade | 2010 |
PublicationYear | 2018 |
RelatedCompanies | Amgen Inc |
RelatedCompanies_xml | – name: Amgen Inc |
Score | 3.1297007 |
Snippet | The present invention provides MDM2 inhibitor compounds of Formula (I), or the pharmaceutically acceptable salts thereof, wherein the variables are defined... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Cis-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180301&DB=EPODOC&locale=&CC=AU&NR=2014219075B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR1NS8Mw9DGmqDedil-THEZvxfXT9jDEtitD6DZ0k91G0ySsIO1YK_59X2I3d9JbSMJL8sL7St4HQI97wkw919C541MdJV5f9x3u69yzslQw6qQqKCwZu6O5_bJwFi342MbCqDyhXyo5IlJUhvReK369_n3EipRvZfVAc-wqn-LZINIa69jwpIavRcFgOJ1Ek1ALQ7QktfGrHLOROFFABsiwD6QiLTPtD98DGZey3hcq8SkcThFeUZ9BixcdOA63tdc6cJQ0X97YbKivOoe3MEfDtETMyEo7ZcFJWjCiQqiIdA2XFZIqklYkiRKT5MUqp7kspkNQMSU4i-y8ykkpSCbve3MBvXg4C0c67m65Q8byeb53lMC0LqEtF7wCwplgmesZgrkZKkm2b9nM9jmnwukb_JFdQ_dPUDf_jN_CicTwjwPWHbTrzSfvokSu6b1C5DefeY_u |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR1NT4Mw9GWZxnnTqfFr2sPCjTgYMDgsRmAL6mCLbmY3ArREEgPLwPj3fa1s7qS3pm1e29e8r_Z9AHSZmaqRaSgy061YRonXky2dWTIz-0mU0liPRFCYHxjeQnta6ssGfGxiYUSe0C-RHBEpKkF6rwS_Xv0-YrnCt7K8izPsKu7H86Er1daxYnINX3Lt4Wg2daeO5DhoSUrBCx_TkDhRQNrIsPcGPD8vV57ebB6XstoVKuMj2J8hvLw6hgbL29ByNrXX2nDg11_e2KyprzyBVydDw7RAzPBKO0XOSJRTIkKoCHcN5xWSShKVxHd9lWT5exZnvJgOQcWU4Cyy9SonRUoSft_rU-iOR3PHk3F34RYZ4cNi5yi22j-DJl_wHAijKU0MU0mpkaCSpFl9jWoWY3Gq9xQ2oBfQ-RPU5T_jt9Dy5v4knDwGz1dwyLH944x1Dc1q_ck6KJ2r-EYg9RuEBpLb |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Cis-morpholinone+and+other+compounds+as+MDM2+inhibitors+for+the+treatment+of+cancer&rft.inventor=Yan%2C+Xuelei&rft.inventor=Beck%2C+Hilary+Plake&rft.inventor=Olson%2C+Steven+H&rft.inventor=Fox%2C+Brian+M&rft.inventor=Julian%2C+Lisa+D&rft.inventor=Degraffenreid%2C+Michael+R&rft.inventor=Roveto%2C+Philip+M&rft.inventor=Bartberger%2C+Michael+D&rft.inventor=Sun%2C+Daqing&rft.inventor=Gonzalez+Lopez+De+Turiso%2C+Felix&rft.inventor=Medina%2C+Julio+C&rft.inventor=Rew%2C+Yosup&rft.inventor=Kayser%2C+Frank&rft.date=2018-03-01&rft.externalDBID=B2&rft.externalDocID=AU2014219075BB2 |